阿拉赛珠单抗
Alacizumab (Anti-VEGFR2 / KDR / CD309)
ChemLeader
Catalog No:
CAS No.:
MDLNo:
Formula:
MW:
Size
1 mg 5 mg 10 mg 50 mg 100 mg
Product Availability
3-5days
Price
$820.00
Member price
Product Availability
3-5days
Price
$2300.00
Member price
Product Availability
3-5days
Price
$4200.00
Member price
Product Availability
3-5days
Price
$19500.00
Member price
Product Availability
3-5days
Price
$34000.00
Member price
Quantity
- +
Product Overview
Product Name Alacizumab (Anti-VEGFR2 / KDR / CD309)
CAS934216-54-3
Storage conditionStore at 2 to 8 °C for 1-2 weeks. Store at -20 °C for 12 months. Store at -80 °C for long term storage. Use a manual defrost freezer and avoid repeated freeze-thaw cycles, away from light.
Security information
Product details

Alacizumab (Anti-VEGFR2 / KDR / CD309) is a humanized monoclonal antibody targeting VEGFR2 / KDR / CD309 . It has anti-tumour effect in tumour growth. MW :144.08 KD.

Related literature
Related
Sorry, no related items
History
Alacizumab (Anti-VEGFR2 / KDR / CD309)
Benralizumab (Anti-IL-5Ra/ CD125)
Anti-Human IL-23 Monoclonal Antibody(Guselkumab)
SNX 2112 | PF-04928473
Pinobanksin 3-acetate ((2R,3R)-Pinobanksin 3-acetate; Pinobanksin 3-O-acetate; Pinobanksin acetate)
Lerdelimumab
Sunitinib | Sunitinib Base
Anti-Human BCMA Monoclonal Antibody(Belantamab biosimilar) mAb; GSK2857914
HCTU; O-(6-Chlorobenzotriazol-1-yl)-N,N,N',N'-tetramethyluronium Hexafluorophosphate/O-(6-Chloro-1-hydrocibenzotriazol-1-yl)- -1,1,3,3-tetramethyluroniumhexafluorophosphate
Artesunate